Leonabio, Inc. · NASDAQ:LONA
Joseph Edelman reported a 20.10% stake in Leonabio, Inc. (Schedule 13D/A)
Event Dec 23, 2025 · Filed Dec 23, 2025
Joseph Edelman reported a 20.10% stake in Leonabio, Inc., 1,869,050 shares, with active intent on Dec 23, 2025. Filed Dec 23, 2025 (Schedule 13D/A).
- Stake
- 20.10%
- Shares
- 1,869,050
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 19.99% | 1,859,322 |
| Joseph Edelman | 20.10% | 1,869,050 |
| Perceptive Life Sciences Master Fund, Ltd. | 16.40% | 1,529,566 |
| Perceptive Xontogeny Venture Fund II, LP | 3.50% | 329,756 |
Source
Related
- Leonabio, Inc.
- Joseph Edelman
- Leonabio, Inc. shareholders
- Schedule 13D/A · Joseph Edelman · Dec 22, 2025
- Schedule 13D · Sermonix Pharmaceuticals, Inc. · Aug 31, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13G/A · Anders Hove · Aug 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026